These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia. Ballo P, Bernabò D, Faraguti SA. Eur Heart J; 2004 Aug; 25(15):1310-7. PubMed ID: 15288158 [Abstract] [Full Text] [Related]
16. A comparison of adenosine and verapamil for the treatment of supraventricular tachycardia in the prehospital setting. Madsen CD, Pointer JE, Lynch TG. Ann Emerg Med; 1995 May; 25(5):649-55. PubMed ID: 7741343 [Abstract] [Full Text] [Related]
17. Adenosine for the treatment of PSVT in the prehospital arena: efficacy of an initial 6 mg dosing regimen. Wittwer LK, Muhr MD. Prehosp Disaster Med; 1997 May; 12(3):237-9. PubMed ID: 10187020 [Abstract] [Full Text] [Related]
18. Adenosine and the treatment of supraventricular tachycardia. Rankin AC, Brooks R, Ruskin JN, McGovern BA. Am J Med; 1992 Jun; 92(6):655-64. PubMed ID: 1605147 [Abstract] [Full Text] [Related]
19. Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings. Ip JE, Bui H, Camm AJ, Coutu B, Noseworthy PA, Parody ML, Sears SF, Singh N, Uribe JA, Vyselaar J, Omodele S, Shardonofsky S, Bharucha DB, Stambler B. Am Heart J; 2024 Apr; 270():55-61. PubMed ID: 38266665 [Abstract] [Full Text] [Related]